The Guide to Life Sciences (Excessive Pricing)

Global Competition Review

Georgios Zacharodimos

Associate George Zacharodimos highlights recent decisions that find an excessive price infringement in the pharmaceuticals sector and how these decisions introduce a cost-plus approach to identify excessive pharmaceutical prices.

An extract from GCR’s The Guide to Life Sciences - First Edition. The whole publication is available at